We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
+17.26%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
AUM
$76.6M
AUM Growth
+$3.5M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYN icon
1
Dyne Therapeutics
DYN
$4.24B
$25M 32.61%
2,220,034
CNTA
2
DELISTED
Centessa Pharmaceuticals
CNTA
$24.3M 31.78%
3,931,818
ALLO icon
3
Allogene Therapeutics
ALLO
$604M
$8.94M 11.67%
1,798,163
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$6.69M 8.73%
2,207,772
LIAN
5
DELISTED
LianBio American Depositary Shares
LIAN
$5.2M 6.79%
2,282,084
KRON
6
DELISTED
Kronos Bio
KRON
$4.76M 6.21%
2,765,314
PRAX icon
7
Praxis Precision Medicines
PRAX
$8.8B
$1.69M 2.21%
97,978

Similar funds

Vida Ventures Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Vida Ventures Advisors held 7 positions worth $76.6M, up 4.8% from $73.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. Vida Ventures Advisors opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's ten largest holdings make up 100% of its $76.6M portfolio in Q2 2023.
  • Vida Ventures Advisors opened 0 new positions and closed 0 in Q2 2023.
  • Vida Ventures Advisors's portfolio value rose 4.8% quarter-over-quarter to $76.6M.

Based on Vida Ventures Advisors's 13F filing for Q2 2023, filed 19 Jul 2023.